Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Travere Therapeutics, Inc. | Financial_Report.xls |
| EX-31 - EXHIBIT 31 CERTIFICATION - Travere Therapeutics, Inc. | exhibit31desertgateway.htm |
| 10-Q - DESERT GATEWAY, INC. FORM 10-Q 05.31.2012 - Travere Therapeutics, Inc. | f120710desertgateway10q05312.htm |
EXHIBIT 32
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Quarterly Report on Form 10-Q of Desert Gateway, Inc., for the quarter ending May 31, 2012, I, Robert Wilson, Chief Executive Officer and Chief Financial Officer, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
1.
Such quarterly Report on Form 10-Q for the quarter ending May 31, 2012, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in such quarterly report on Form 10-Q for the quarter ended May 31, 2012, fairly represents in all material respects, the financial condition and results of operations of Desert Gateway, Inc.
Dated: July 10, 2012 |
DESERT GATEWAY, INC.
By: | /s/ Robert Wilson Chief Executive Officer and Chief Financial Officer |